Search This Blog

Thursday, January 23, 2020

Epizyme target upped to $35 from $25 by Citigroup

Maintains Buy
https://www.benzinga.com/stock/EPZM/rating

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.